Circovirus sequences associated with piglet weight loss disease (PWD)
Patent 7407803 Issued on August 5, 2008. Estimated Expiration Date: July 17, 2026. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-strucutral polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccines, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.
Other References
Zhao, T.M. et al., 1996, Proc. Natl. Acad. Sci., USA 93(13): 6653-6648.
Young, John A. T. et al., “Efficient Incorporation of Human CD4 Protein into Avian Leukosis Virus Particles”, Reports, 1421-14723, 1990.
White, B.A. et al. Eds, “PCR Cloning Protocol” in Methods in Molecular Biology, 67, Humana Press, Towota, 1997.
Walker, G.T. et al., 1992, Proc. Nat'l Acad. Sci., USA, 89: 392-396.
Walker, G.T. et al., 1992, Nucleic Acids Res. 20: 1691-1696.
Virus Taxonomy, Murphy, F.A. et al., Ed. 1995, Sixth Report of the International Committee on Taxonomy of Viruses, Springer-Verlag Wien New York.
Valsesia-Whittmann, Sandrine et al., 1996, “Improvement of Retroviral Retargeting by Using Amino Acid Spacers between an Additional Binding Domain and the N Terminus of Moloney Nurine Leukemia Virus SU”, J. Virol, 70(3): 2059-2064.
Tischer, I. et al., 1995, Arch. Virol., 140: 737-743.
Tischer, I. et al., 1986, Arch. Virol., 91: 271-276.
Tischer, I. et al., 1982, Nature, 295: 64-66.
Tischer, I. and Bohk, H.J., 1988, Zentralbl Bakteriol Mikrobiol Hyg [A] 270: 280-287.
Tascon, R.E. et al., 1996, Nature Medicine, 2(8): 888-892.
Smith, Temple F. et al., 1981, “Comparison of Biosequences”, Advances in Applied Mathematics, 2: 482-489.
Shiver, J. W., “Immune Responses to HIV gp120 Elicited by DNA Vaccination,” in Vaccines, 1995, eds Chanock, et al., pp. 95-98, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Ségales, J. et al., “First Report of Post-Weaning Multisystemic Wasting Syndrome in Pigs in Spain”, Beterinary Record, col. 141, No. 23, pp. 600-601, Dec. 1997, XP-002068504.
Sanchez-Pescador, R., 1988, J. Clin. Microbiol., 26(10): 1934-1938.
Sambrook, J. et al., 1989, Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Rose, N. et al., 2002, “Risk Factors for Porcine Post-Weaning Multisystemic Wasting Syndrome (PMWS) in 149 French Farrow-to-Finish Herds”, Preventive Veterinary Microbiology, 61: 209-225.
Rolfs, A. et al., “Usage of Polymerase Chain Reaction in Genetic and Infectious Disease” in PCR Topics, 1991, Springer-Verlag, Berlin.
Pearson, William R. et al., 1988, “Improved Tools for Biological Sequence Comparison”, Proc. Nat'l Acad, Sci., USA, 85: 2444-2448.
Neddleman, Saul B. et al., 1970, “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins”, J. Mol. Biol., 48(3): 443-453.
Nayar, G.P. et al., 1997, Can. Vet. J. 38(6): 385-386.
Müller, 1974, in Methode der Organischen Chemie, E. Wunsch Ed., vol. 15-I and 15-II, Thieme, Stuttgart.
Morozov, I. et al., “Detection of a Novel Strain of Procine Circovirus in Pigs with Postweaning Multisystemic Wasting Syndrome”, Journal of Clinical Microbiology, col. 36, No. 9, pp. 2535-2541, Sep. 1998, XP-002090921.
Miele, E.A. et al., 1983, J. Mol. Biol., 171: 281-295.
Meehan, B.M. et al., 1997, J. Gen. Virol. 78: 221-227.
McNeilly, F. et al., 1996, Vet. Immunol. Immunopathol., 49: 295-306.
Matthews, J.A. et al., 1988, Anal. Biochem., 169: 1-25.
Marglin, A. and Merrifield, R.B., 1966, J. Am. Chem. Soc., 88(21): 5051-5052.
Mankertz, A. et al., 1997, J. Virol., 71: 2562-2566.
Luckow, V.A., 1993, Baculovirus systems for the expression of human gene products. Curr. Op. Biotechnol. 4: 564-572.
Liu et al., 1997, J. Gen. Virol., 78 (Pt 6), 1265-1270.
Lazarowitz, S.G. et al., 1989, The EMBO Journal, vol. 8, No. 4: 1023-1032.
Ladany, S. et al., 1989, J. Clin. Microbiol. 27: 2778-2783.
Kwoh, D.Y. et al., 1989, Proc. Nat'l Acad. Sci., USA, 86: 1173-1177.
Kohler, G. & Milstein, 1975, Nature, 256(5517): 495-497.
Kievitis, T. et al., 1991, J. Virol. Methods, 35: 273-286.
Kessler, C., “Overview of Amplification on Systems” in Non-radioactive Labeling and Detection of Biomolecules, 1992, Springer Verlag, Berlin, New York: 197-205.
Kasahara, Noriyuki et al., 1994, “Tissue-Specific Targeting of Retroviral Vectors Through Ligan-Receptor Interactions”, Science, 266: 1373-1376.
Kaneda, et al., 1989, Science, 243: 375-378.
Innis, M.A. et al., 1990, in PCR Protocols. A guide to Methods and Applications, San Diego, Academic Press.
Huygen, K. et al., 1996, Nature Medicine, 2(8): 893-898.
Horner, G.W., 1991, Surveillance 18(5): 23.
Heyraud-Nitschke, F. et al., 1995, Nucleic Acids Research, vol. 23, No. 6: 910-916.
Harding, R.M. et al., 1993, Journal of General Virology, 74: 323-328.
Harding, J.C., 1997, American Association of Swine Practitioners, 503.
Harding, J.C. and Clark, E.G., 1997, Swine Health and Production, vol. 5, No. 5: 201-203.
Hanson, S.F. et al., 1995, Virology, 211: 1-9.
Hamel, A. et al., “Nucleotide Sequence of Procine Circovirus Associated with Postweaning Multisystemic Wasting Syndrome in Pigs”, Journal of Virology, col. 72, No. 6, pp. 5262-5267, Jun. 1998, XP-002078783.
Hackland, A.F. et al., 1994, Arch. Virol., 139: 1-22.
Guateli, J.C. et al., 1990, Proc. Nat'l Acad. Sci., USA, 87: 1874-1878.
Fraley et al., 1980, J. Biol. Chem., 255: 10431-10435.
Fontes, E.P.B. et al., 1994, J. Biol. Chem., vol. 269, No. 11: 8459-8465.
Felgner, et al., 1987, Proc. Natl. Acad. Sci., 84: 7413-7417.
Erlich, H.A., 1989, In PCR Technology. Principles and Applications for DNA Amplification. New York: Stockton Press.
Ellis, J. et al., “Isolation of Circovirus from legions of pigs with Postweaning Multisystemic Wasting Syndrome”, Canadian Veterinary Journal, col. 39, pp. 44-51, Jan. 1998, XP-002068502.
Edwards, S. et al., 1994, Vet. Rec., 134: 680-681.
Edwards, C.P., and Aruffo, A., 1993, Current applications of COS cell based transient expression systems. Curr. Op. Biotechnology 4: 558-563.
Dulac, G.C. et al., 1989, Can. J. Vet. Res., 53: 431-433.
Duck, P. et al., 1990, Biotechniques, 9: 142-147.
Dialog Inpadoc Family and Legal Status Search for WO 02/102999, 2002.
Dialog Inpadoc Family and Legal Status Search for WO 01/96377, 2001.
Dialog Inpadoc Family and Legal Status Search for German Patent Appl. No. 10044648, 2000.
Derwent Abstract of French Patent Appl. No. 2518755, 1983.
Derwent Abstract of French Patent Appl. No. 2422956, 1979.
Derse, D. et al., 1995, J. Virol., 69(3): 1907-1912.
Daft, B. et al., 1996, American Association of Veterinary Laboratory Diagnosticians, 32.
Cosset, Francois-Loic et al., 1995, “Retroviral Retargeting by Envelopes Expressing an N-Terminal Binding Domain”, J. Virol., 69:6314-6322.
Clark, E.G., 1997, American Association of Swine Practitioners, 499-501.
Chu, Te-hua Terina et al., 1997, “Toward Highly Efficient Cell-Type-Specific Gene Transfer with Retroviral Vectors Displaying Single-Chain Antibodies”, J. Virol., 71(1): 720-725.
Chu P.W.G. et al., 1993, Virus Research, 27: 161-171.
Chu, B.C.F. et al., 1986, NAR, 14: 5591-5603.
Burg, J.L. et al., 1996, Mol. and Cell. Probes, 10: 257-271.
Buckholz, R.G., 1993, Yeast systems for the expression of heterologous gene products. Curr. Op. Biotechnology 4: 538-542.
Blanchard et al., 2003, “Protection of Swine Against Post-Weaning Multisystemic Wasting Syndrome (PMWS) by Porcine Circovirus Type 2 (PCV2) Proteins”, Vaccine 21: 4565-4575.
Blanchard et al., 2003, “An ORF2 Protein-Based Elisa for Procine Circovirus Type 2 Antibodies in Post-Weaning Multisystemic Syndrome”, Veterinary Microbiology, 94: 183-184.
Author Unknown, GenBank info on AF027217 (Revised Jul. 5, 2002).
Allan, G.M. et al., 1995, Vet. Microbiol., 44: 49-64.
Allan, G. M. et al., “Isolation of Procine Circovirus-like Viruses from Pigs with a Wasting Disease in the USA and Europe”, Journal of Veterinary Diagnostic Investigation, vol. 10, pp. 3-10, Jan. 1998, XP 002068503.
U.S. Appl. No. 60/069,233, filed Dec. 11, 1997, Wang et al.
U.S. Appl. No. 60/069,750, filed Dec. 16, 1997, Wang et al.
Zhang, Michael Q. “Large Scale Gene Expression Data Analysis: A New Challenge to Computational Biologists,” Genome Research, 9(8):681-688 (1999).
Yokoyama et al. “DNA immunization: Effects of vehicle and route of administration on the induction of protective antiviral immunity,” FEMS Immunology and Medical Microbiology, 14:221-230 (1996).
Xiang Z. et al., “Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines,” Immunity, 2:129-135 (1995).
Wheeler, C.J. et al., “Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes,” Biochemica et Biophysica Acta 1280:1-11, XP 002035803 (1996).
West et al., “Myocarditis and abortion associated with intrauterine infection of sows with porcine circovirus 2” J Vet Diagn Invest. 11: 530-532 (1999).
Wen, L. et al., “Genotyping of porcine circovirus type 2 from a variety of clinical conditions in China,” Veterinary Microbiology, 110 (2005) pp. 141-146.
Watanabe, Y et al., “Highly Efficient Transfection into Primary Cultured Mouse Hepatocytes by Use of Cation-Liposomes: An Application for Immunization,” J. Biochem. 116:1220-1226 (1994).
Walker, G.T. et al., Nucleic Acids Res. (1992) 20: 1691-1696.
Vannier, et al., “Study of the Efficacy of an Inactivated Virus Vaccine Against Porcine Parovirus,” Ann. Rech. Vet. 17(4):425-432 (1986).
Todd et al., “Comparison of Three Animal Viruses with Circular Single-Stranded DNA Genomes,” Arch Virol., 117:129-135 (1991).
Terpestra et al., “Potentcy control of modified live viral vaccines for veterinary use,” Vaccine 14(6):570-575 (1996).
Somasundaram, C. et al., “Enhanced Protective Response and Immuno-Adjuvant Effects of Porcine GM-CSF on DNA Vaccination of Pigs against Aujeszky's Disease Virus,” Veterinary Immunology and Immunopathology 70:277-287 (1999).
Sin, J-I et al., “Protective Immunity Against Heterologous Challenge with Encephalomyocarditis Virus by VP1 DNA Vaccination: Effect of Coinjection with a Granulocyte-Macrophage Colony Stimulating Factor Gene,” Vaccine 15:1827-1833 (1997).
Schultz, J et al., “Update on Antiviral DNA Vaccine Research (1998-2000),” Intervirology; 43:197-217 (2000).
Schena, Mark et al. “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes,” Proc. Natl. Acad. Sci. USA, 93:10614-10619 (1996).
Schena, Mark, et al. “Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray,” Science, 270:467-470 (1995).
Ruitenberg, K. M. et al., “DNA-Mediated Immunization with Glycoprotein D of Equine Herpesvirus 1 (EHV-1) in a Murine Model of EHV-1 Respiratory Infection,” Vaccine, 17:237-244 (1999).
Restifo, N P et al. “The promises of nucleic acid vaccines,”, Gene Therapy, 7:89-92 (2000).
Parker, SE et al., “Plasmid DNA gene therapy: Studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo,” Cancer Gene Therapy, 3(3):175-185 (1996).
Okada, E. et al., “Intranasal immunization of a DNA vaccine with 1L-I2- and Granulocyte-macrophage colony-stimulating Factor (GM-(SF)).-expressing plasmids in Liposomes Induces Strong Mucosal and Cell-Mediated immune responses against HIV-1 antigens,” The Journal of Immunology, 159:3638-3647 (1997).
Nuwaysir, Emile F. et al. “Microarrays and Toxicology: The Advent of Toxicogenomics,” Molecular Carcinogenesis, 24:153-159 (1999).
Norman, JA et al., “Development of Improved Vectors for DNA-Based Immunization and other Gene Therapy Applications,” Vaccine, 15(8): 801-803 (1997).
Nieuwkoop and Faber “Normal Table of Xenopus laevis (Daudin)—A Systematic and chronological survey of the development from the fertilized egg to the end of metamorposis,” Chapter VII, 162-188 Garland Publishing(1994).
Newport, John et al. “A Major Developmental Transition in Early Xenopus Embryos: II. Control of the Onset of Transcription,” Cell 30:687-696 (1982).
Newport, John et al., “Major Developmental Transition in Early Xenopus Embryos: I. Characterization and Timing of Cellular Changes at the Midblastula Stage,” Cell 30:675-686 (1982).
Nayer et al., “Detection and Characterization of Porcine Circovirus Associated With Postweaving Multisystemic Wasting Syndrome Pigs”, Can Vet. J. 38:385-386 (1997).
Nawagtigul et al., “Open Reading Frame 2 of Porcine Circovirus Type 2 Encodes a Major Capsid Protein”, Journal of General Virology 81:2281-2287 (2000).
Nash RA et al., “Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor” Blood 78(4):930-937, XP 002133949 (1991).
Nakakura, Norihiko et al. “Synthesis of Heterogeneous mRNA-like RNA and Low-Molecular-Weight RNA before the Midblastula Transition in Embryos of Xenopus laevis,” Develomental Biology, 123:421-429 (1987).
Mumford J. A. et al. “Antigenicity and immunogenicity of equine infleuenza vaccines containing a Carbomer adjuvant,” Epidemiol. Infect. 112: 421-437 (1994).
Miller, J.S. et al., “The nucleotide sequence of RNA-1 of Indian peanut clump furovirus” Arch. Virol. 141:2301-2312, (1996).
Meehan, B.M. et al., “Characterization of noval circovirus DNAs associated with wasting syndromes in pigs.”, Journal of General Virology, vol. 79, No. 9, pp. 2171-2179, Sep. 1998, XP-002090386.
Meehan et al., “Putative PCV Replication-Associated Protein (REP)”, EMBL Sequence Database XP 002104867 (1997).
McInnes, C.J. et al., “Cloning and Expression of a cDNA Encoding Ovine Granulocyte-Macrophage Colony-Stimulating Factor” Gene, 105: 275-279, XP-002148815 (1991).
McCluskie, Michael J. et al., “Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates” Molecular Medicine 5:287-300 (1999).
Mankertz et al., “Porcine Circovirus Complete Genome”, EMBL Sequence Database XP-002104869 May 22, 1997.
Mahé et al., “Differential Recognition of ORF 2 Protein from Type 1 and Type 2 Porcine Circoviruses and Identification of Immunorelevant Epitopes”, Journal of General Virology 81:1815-1824 (2000).
Lekcharoensuk, P. et al., “Epitope Mapping of the Major Capsid Protein of Type 2 Porcine Circovirus (PCV2) by Using Chimeric PCV1 and PCV2,” Journal of Virology, vol. 78, No. 15, Aug. 2004, pp. 8135-8145.
LeCann et al., “Piglet Wasting disease,” Veterinary Record, p. 660, Dec. 20/27, 1997.
Krakowka et al., “Immunologic Features of Porcine Circovirus Type-2 Infection,” Viral Immunology. 15 (4): 567-582 (2002).
Krakowka et al., “Activation of the Immune System in the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2),” Vet Pathology. 38:31-42 (2001).
Knell, S. et al., “Comparative genetic characterization of Porcine Circovirus type 2 samples from German wild boar populations,” Veterinary Microbiology, 109 (2005) pp. 169-177.
Klavinskis, Linda S. et al., “Intranasal Immunization with Plasmid DNA-Lipid Complexes Elicits Mucosal Immunity in the Female Genital and Rectal Tracts” J. Immunol 1999, pp. 254-262.
Izumida, et al., “Establishment of the Attenuated Strain of Porcine Parvovirus of the Live Vaccine and its Biological-Immunological Characteristics,” Japanese Veterinary Science, 48(2):293-303 (1996).
Ishii N. et al., “Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1” AIDS Res Hum Retroviruses, Nov. 1, 1997 13(6):1421-1428.
Inumaru, S. et al., “cDNA Cloning of Porcine Granulocyte-Macrophage Colony-Stimulating Factor” Immunology and Cell Biology, 73:474-476, XP-000946635 (1995).
Hamel et al., “Porcine Circovirus,” (Sequence Alignments for SEQ ID Nos. 1-4 and 6) Genbank Acc. No. 027217, Dec. 19, 1997.
Haddad, D. et al., “Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody in mice,” FEMS Immunology and Medical Microbiology, 18(3):193-202 (1997).
Grierson, S.S., et al., “Genome sequence analysis of 10 Dutch porcine circovirus type 2 (PCV-2) isolates from a PMWS case-control study,” Research in Veterinary Science, 77 (2004) pp. 265-268.
Gregoriadis G. et al., “Liposome-mediated DNA vaccination” FEBS Letters, Feb. 3, 1997; 402:107-110.
GenBank Accession No. AF027217; May 14, 1998.
Fort, Douglas J. et al. “Evaluation of the Developmental Toxicity of Thalidomide Using Frog Embryo Teratogenesis Assay—Xenopus (FETAX): Biotransformation and Detoxification,” Teratogensis, Carcinogenesis, and Mutagenesis, 20:35-47 (2000).
Fenaux, M. et al., “Genetic Characterization of Type 2 Porcine Circovirus (PCV-2) from Pigs with Postweaning Multisystemic Wasting Syndrome in Different Geographic Regions of North America and Development of a differential PCR-Restriction Fragment Length Polymorphism Assay to Detect and Differentiate between Infections with PCV-1 and PCV-2,” Journal of Clinical Microbiology, Jul. 2000, 38(7):2494-2503.
Felgner J.H. et al., “Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations,” The journal of biological chemistry, 269(4)2550-2561 (1994).
Ertl, H.C.J. et al., “Genetic Immunization” Viral Immunology, 9(1):1-9 (1996).
Ellis et al., “Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome” J. Vet. Diagn. Invest. 12(1):21-27 (2000).
Ellis et al., “Reproduction of lesions of Post eaning multisystemic wasting syndrome in gnotobiotic piglets,” J. Vet. Diagn. Invest. 11:3-14 (1999).
Dorland's Illustrated Medical Dictionary, 28th edition. Philadelphia. WB Saunders p. 1787 (1994).
Donnelly, John J. et al., “Immunization with DNA” Journal of Immunological Methods, 176:145-152 (1994).
DMRIE structure, Printed from PubChem Compound Summary 2008.
Dedet, V., “Seule certitude: un maladie à part entière,” La Semaine Veterinaire p. 54, May 24, 1997.
Cruse et al., “The Illustrated Dictionary of Immunology,” 2nd edition. Boca Raton: CRC Press (2003) p. 613.
Cruse et al., “The Illustrated Dictionary of Immunology,” Boca Raton: CRC Press (1995) p. 156.
Cho et al., “Enhanced cellular immunity of hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization,” Vaccine 17:1136-1144 (1999).
Bei, R. et al., “The Use of a Cationic Liposome Formulation (DOTAP) Mixed with a Recombinant Tumor-Associated Antigen to Induce Immune Responses and Protective Immunity in Mice,” Journal of Immunotherapy, 21(3):159-169 (1998).
Behr, J.P., “Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy” Bioconjugate Chem. 5(5):382-389 (1994).
Bantle, John A. et al. “Phase III Interlaboratory Study of FETFAX Part 3. FETFAX Validation using 12 Compounds with and without an Exogenous Metabolic Activation System,” Journal of Applied Toxicology, 19:447-472 (1999).
Altmann, Curtis R. et al. “Microarray-Based Analysis of Early Development in Xenopus laevis,” Developmental Biology, 236:64-75 (2001).
Allan, G.M., et al., “Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus,” Veterinary Immunology and Immunopathology, 43 (1994) 357-371.
Allan et al., “Immunostimulation, PCV-2 and PMWS,” Veterinary Record (2000); 147(6):170-171.
Allan et al., “Porcine Circoviruses: A Review,” J Vet Diagn Invest. 12: 3-14 (2000).
Albina et al., “Premiers résultats du CNEVA sur le dépérissement fatal du porcelet en fin de post-sevrage” La Semaine Veterinaire des Filieres, 26:1-2, Nov. 30, 1996.
Adams, Mark D. et al. “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project,” Science, 1651-1656. (1991).
ABI-Prism , “Automated DNA Sequencing, Chemistry Guide”, Applied Biosystems, product manual, applicable to automated sequencers ABI Prism 310, 377 and 373 (2000).
July 17, 2026. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
